PON1 as a model for integration of genetic, epigenetic, and expression data on candidate susceptibility genes

Environmental Epigenetics

Volumn 1, Issue 1, 2015, Pages

  Huen, Karen ^a   Yousefi, Paul ^a   Street, Kelly ^a   Eskenazi, Brenda ^a   Holland, Nina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

arylesterase; mediation; methylation; paraoxonase

Indexed keywords

EID: 84979624072     PISSN: None     EISSN: 20585888     Source Type: Journal    
DOI: 10.1093/eep/dvv003     Document Type: Article

References (60)

1. Tammen SA, Friso S, Choi SW. Epigenetics: The link between nature and nurture. Mol Aspects Med 2013;34:753-64.
2. Schubeler D. Function and information content of DNA methylation. Nature 2015;517:321-6.
3. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005;6:597-610.
4. Tammen SA, Friso S, Choi SW. Epigenetics: The link between nature and nurture. Mol Aspects Med 2012;34:753-764.
5. Waterland RA. Is epigenetics an important link between early life events and adult disease Horm Res 2009;71(Suppl 1):13-6.
6. Bailey KA, Wu MC, Ward WO et al. Arsenic and the epigenome: Interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol 2013;27:106-15.
7. De Jager PL, Srivastava G, Lunnon K et al. Alzheimer's disease: Early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 2014;17:1156-63.
8. Joubert BR, Haberg SE, Nilsen RM et al. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 2012;120:1425-31.
9. Swan EJ, Maxwell AP, McKnight AJ. Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with type 1 diabetes. Diabet Med 2015;32:1110-1115.
10. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
11. Liu Y, Li X, Aryee MJ, Ekstrom TJ et al. GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. Am J Hum Genet 2014;94: 485-95.
12. Shoemaker R, Deng J, Wang W et al. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res 2010;20:883-9.
13. Huang YT. Integrative modeling of multiple genomic data from different types of genetic association studies. Biostatistics 2014;15:587-602.
14. Kundaje A, Meuleman W, Ernst J et al. Integrative analysis of 111 reference human epigenomes. Nature 2015;518:317-30.
15. Li HL, Liu DP, Liang CC. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 2003;81:766-79.
16. Harley KG, Huen K, Schall RA et al. Association of organophosphate pesticide exposure and paraoxonase with birth outcome in Mexican-American women. PLoS One 2011;6: E23923.
17. Infante-Rivard C. Genetic association between single nucleotide polymorphisms in the paraoxonase 1 (PON1) gene and small-for-gestational-age birth in related and unrelated subjects. Am J Epidemiol 2010;171:999-1006.
18. Lawlor DA, Day IN, Gaunt TR et al. The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: Findings from the British Women's Heart and Health Study. J Epidemiol Community Health 2007;61:85-7.
19. Leduc V, Poirier J. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: Emphasis on the cholinergic system and beta-amyloid levels. Neurodegener Dis 2008;5:225-7.
20. Ryckman KK, Morken NH, White MJ et al. Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth. PLoS One 2010;5:e9040.
21. Eskenazi B, Huen K, Marks A et al. PON1 and neurodevelopment in children from the CHAMACOS study exposed to organophosphate pesticides in utero. Environ Health Perspect 2010;118:1775-81.
22. Eskenazi B, Kogut K, Huen K et al. Organophosphate pesticide exposure, PON1, and neurodevelopment in school-age children from the CHAMACOS study. Environ Res 2014;134C: 149-57.
23. Furlong CE, Holland N, Richter RJ et al. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics 2006;16: 183-90.
24. Holland N, Furlong C, Bastaki M et al. Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns. Environ Health Perspect 2006;114:985-91.
25. Liu ME, Liao YC, Lin RT et al. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. Atherosclerosis 2013;228:161-7.
26. Holland N, Lizarraga D, Huen K. Recent progress in the genetics and epigenetics of paraoxonase: Why it is relevant to children's environmental health. Curr Opin Pediatr 2015;27: 240-7.
27. Schrader C, Rimbach G. Determinants of paraoxonase 1 status: Genes, drugs and nutrition. Curr Med Chem 2011;18: 5624-43.
28. de la Iglesia RMM, Sanchez-Muniz FJ, Zulet MA et al. Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (pon1) gene methylation in metabolic syndrome patients following an energy restricted diet. EXCLI J 2014;13:416-26.
29. Carlson CS, Heagerty PJ, Hatsukami TS et al. TagSNP analyses of the PON gene cluster: Effects on PON1 activity, LDL oxidative susceptibility, and vascular disease. J Lipid Res 2006;47: 1014-24.
30. Deakin S, Leviev I, Brulhart-Meynet MC et al. Paraoxonase-1 promoter haplotypes and serum paraoxonase: A predominant role for polymorphic position-107, implicating the Sp1 transcription factor. Biochem J 2003;372:643-9.
31. Huen K, Barcellos L, Beckman K et al. Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children. Environ Mol Mutagen 2011;52:105-16.
32. Emsley R, Liu H, Dunn G et al. PARAMED: Stata module to perform causal mediation analysis using parametric regression models 2013. Available: Https://ideas.repec.org/c/boc/bocode/s457581.html (4 March 2015, date last accessed).
33. Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: Theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 2013;18:137-50.
34. Bonder MJ, Kasela S, KalsMet al. Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics 2014;15:860.
35. Schalkwyk LC, Meaburn EL, Smith R et al. Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet 2010;86:196-212.
36. Gertz J, Varley KE, Reddy TE et al. Analysis of DNA methylation in a three-generation family reveals widespread genetic influence on epigenetic regulation. PLoS Genet 2011;7: E1002228.
37. Meaburn EL, Schalkwyk LC, Mill J. Allele-specific methylation in the human genome: Implications for genetic studies of complex disease. Epigenetics 2010;5:578-82.
38. Blattler A, Farnham PJ. Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem 2013;288:34287-94.
39. Osaki F, Ikeda Y, Suehiro T et al. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. Atherosclerosis 2004;176: 279-287.
40. Holler M, Westin G, Jiricny J et al. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 1988;2:1127-35.
41. Costa LG, Giordano G, Furlong CE. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on. Biochem Pharmacol 2011;81: 337-44.
42. Eskenazi B, Bradman A, Gladstone E et al. CHAMACOS, a longitudinal birth cohort study: Lessons from the fields. J Childrens Health 2003;1:3-27.
43. ISBER. 2012 best practices for repositories: Collection, storage, retrieval, and distribution of biological materials for research. Biopreserv Biobank 2012;10:79-161.
44. Richter RJ, Furlong CE. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 1999;9:745-53.
45. Connelly PW, Maguire GF, Picardo CM et al. Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma. J Lipid Res 2008;49: 245-50.
46. Kujiraoka T, Oka T, Ishihara M et al. A sandwich enzymelinked immunosorbent assay for human serum paraoxonase concentration. J Lipid Res 2000;41:1358-63.
47. Huen K, Richter R, Furlong C et al. Validation of PON1 enzyme activity assays for longitudinal studies. Clin Chim Acta 2009;402:67-74.
48. Bibikova M, Barnes B, Tsan C et al. High density DNA methylation array with single CpG site resolution. Genomics 2011;98:288-95.
49. Sandoval J, Heyn H, Moran S et al. Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics 2011;6:692-702.
50. Yousefi P, Huen K, Schall RA et al. Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies. Epigenetics 2013;8: 1141-52.
51. Teschendorff AE, Marabita F, Lechner M et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 2013;29:189-96.
52. Du P, Zhang X, Huang CC et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010;11:587.
53. Yousefi P, Huen K, Quach H, Motwani G, Hubbard A, Eskenazi B, Holland N. Estimation of blood cellular heterogeneity in newborns and children for epigenome-wide association studies. Environ Mol Mutagen. In Press.
54. Houwen B. The differential cell count. Lab Hematol 2001;7: 89-100.
55. Aryee MJ, Jaffe AE, Corrada-Bravo H et al. Minfi: A flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014;30:1363-9.
56. Dallman P. Blood and blood-forming tissues. In: A Rudolph (ed.), Paediatrics. New York: Appleton-Century-Crofts, 1977, 1109-12.
57. Nathan D, Oski F, Orkin S. Nathan and Oski's Hematology of Infancy and Childhood, Vol. 2, 6 edn. Philadelphia, PA: Saunders, 2003.
58. Huang YT. Integrative modeling of multi-platform genomic data under the framework of mediation analysis. Stat Med 2015;34:162-78.
59. Koestler DC, Chalise P, Cicek MS et al. Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer. BMC Med Genomics 2014;7:8.
60. Liu Y, Aryee MJ, Padyukov L et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013;31: 142-7.